ROUNDTABLE SESSIONS

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

Roundtable 1
Progressing your planning as a small biotech whilst in funding mode
Judi Simonsen, CEO and Co-Founder, MERODZ

Roundtable 2
Selecting and managing sites: key considerations
Catharina Ă–stberg, Head of Site Management Nordics, Bayer

Roundtable 3
Considering sustainability throughout the clinical supply chain: where can we improve?
Kamal Amin, Head of Supply Chain Management, Galderma

Roundtable 4
Integrating AI into clinical operations
Pietro Belligoli, Researcher, Former Roche

Agentic AI use cases in clinical trials

  • Evolution of Agentic AI in clinical trials
  • A framework to select the right use cases to implement Agentic AI
  • Practical examples of building agentic AI use cases across clinical development
  • Deep dive into AI implementation around RTSM activities